HDL remodeling and enrichment with apoCIII and apoE in Indigenous Australians
Journal of Clinical Lipidology · 2025
DOI: 10.1016/j.jacl.2025.08.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Lipidology, 2025. Verfasst von Maaike Kockx und 6 weiteren Autor:innen. Beteiligte Einrichtung: ANZAC Research institute, Concord Repatriation General Hospital and University of Sydney, Sydney, NSW, Australia (Drs Kockx, Wang, and Kritharides). Hauptthemen laut MEDLINE: Apolipoproteins E, Lipoproteins, HDL. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hospital Research Foundation, New South Wales Ministry of Health, Medical Research Future Fund.
Abstract (Originalsprache)
BACKGROUND: Indigenous Australians have an increased risk of type 2 diabetes mellitus (T2DM) and premature cardiovascular disease. Subpopulations of high-density lipoprotein (HDL) have been associated with increased cardiovascular risk, but HDL composition, size, or function have not been studied in Indigenous Australians. METHODS: The study consisted of 86 non-Indigenous participants, 43 of whom had T2DM, and 75 Indigenous participants, 36 of whom had T2DM. HDL lipid and apolipoprotein content were determined using enzymatic assays and enzyme-linked immunosorbent assays, respectively, and HDL size and distribution were investigated using nuclear magnetic resonance spectroscopy. Transporter-independent, ATP-binding cassette transporter (ABC)A1- and ABCG1-specific cholesterol efflux capacity (CEC) were determined using cell lines stably expressing human ABCA1 or ABCG1. RESULTS: Indigenous participants had significantly lower concentrations of large (10.3-12.0 nm), small (7.4-7.8 nm), and total HDL particles, which persisted after adjustment for serum triglyceride (TG), body mass index (BMI), and T2DM. HDL from Indigenous Australians was also highly enriched in TG, apolipoprotein (apo) E, and apoCIII (all P < .001). Transporter-independent and ABCG1-mediated CEC were not different between the populations. ABCA1-specific CEC per HDL particle was higher in Indigenous than in non-Indigenous subjects (P < .001), and persisted after adjustment for TG, BMI, and T2DM. Multivariable analysis identified that ABCA1-specific CEC was independently and positively associated with HDL-apoCIII and HDL-apoE levels. CONCLUSIONS: Indigenous Australians demonstrate significant compositional, size, and functional changes in circulating HDL, which is only partially explained by BMI, hypertriglyceridemia, or T2DM. Remodeled HDL may serve as a biomarker of increased cardiovascular risk in Indigenous Australians.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ANZAC Research institute, Concord Repatriation General Hospital and University of Sydney, Sydney, NSW, Australia (Drs Kockx, Wang, and Kritharides).
- Wardliparingga Aboriginal Health Equity, South Australian Health and Medical Research Institute, and Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia (Dr Howard, Brown).
- Department of Endocrinology and Metabolism, Concord Repatriation General Hospital, Sydney Local Health District and University of Sydney, Sydney, NSW, Australia (Dr Suryawanshi).
- Victorian Heart Institute, Monash University, Clayton, VIC, Australia (Dr Nicholls).
- Wardliparingga Aboriginal Health Equity, South Australian Health and Medical Research Institute, and Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia (Dr Howard, Brown); National C…
- ANZAC Research institute, Concord Repatriation General Hospital and University of Sydney, Sydney, NSW, Australia (Drs Kockx, Wang, and Kritharides); Department of Cardiology, Concord Repatriation General Hospital, Sydne…
Förderung
- Hospital Research Foundation
- New South Wales Ministry of Health
- Medical Research Future Fund
- National Health and Medical Research Council
- South Eastern Sydney Local Health District
Zitieren
APA
Kockx, M., Wang, J., Howard, N. J., Suryawanshi, A., Nicholls, S. J., Brown, A., & Kritharides, L. (2025). HDL remodeling and enrichment with apoCIII and apoE in Indigenous Australians. Journal of Clinical Lipidology. https://doi.org/10.1016/j.jacl.2025.08.006
Vancouver
Kockx M, Wang J, Howard NJ, Suryawanshi A, Nicholls SJ, Brown A, et al. HDL remodeling and enrichment with apoCIII and apoE in Indigenous Australians. Journal of Clinical Lipidology. 2025. doi:10.1016/j.jacl.2025.08.006
BibTeX
@article{Kockx2025,
author = {Kockx, Maaike and Wang, Jeffrey and Howard, Natasha J and Suryawanshi, Avinash and Nicholls, Stephen J and Brown, Alex and Kritharides, Leonard},
title = {HDL remodeling and enrichment with apoCIII and apoE in Indigenous Australians},
journal = {Journal of Clinical Lipidology},
year = {2025},
doi = {10.1016/j.jacl.2025.08.006}
}
EUVIMED